Covenant Partners, LLC Castle Biosciences Inc Transaction History

Covenant Partners, LLC

  • $337 Million
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 11, 2021
SELL
$58.92 - $97.33 $549,664 - $907,991
-9,329 Reduced 30.48%
21,279 $1.46 Million
Q3 2020

Nov 10, 2020
SELL
$38.47 - $52.03 $827,258 - $1.12 Million
-21,504 Reduced 41.26%
30,608 $1.58 Million
Q2 2020

Aug 17, 2020
SELL
$27.28 - $43.01 $88,168 - $139,008
-3,232 Reduced 5.84%
52,112 $1.96 Million
Q1 2020

May 15, 2020
BUY
$23.08 - $35.53 $1.28 Million - $1.97 Million
55,344 New
55,344 $1.65 Million

Others Institutions Holding CSTL

# of Institutions
162
Shares Held
25.3M
Call Options Held
82.2K
Put Options Held
150K
View Full List

About CASTLE BIOSCIENCES INC

CSTL Quotes by TradingView
  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $559M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Covenant Partners, LLC Portfolio

Follow Covenant Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covenant Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Covenant Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email